Phase
Condition
Eczema (Atopic Dermatitis - Pediatric)
Rash
Atopic Dermatitis
Treatment
N/AClinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Females and males between 18 and 65 years of age
Caucasian
AD according to the criteria of Hanifin and Rajka (12) with eczematous lesionscorresponding to an Atopic Dermatitis Severity Index (ADSI) (13) score of at least 6on any of the following areas: arms, legs, chest, abdomen or back
No serious health conditions that may interfere with the study
Written informed consent
Exclusion
Exclusion Criteria:
Eczematous regions exclusively in intertriginous areas or in the face
Use of topical steroids or any other dermatologic drug therapy (moisturising creamsallowed) in the study area or light therapy within the preceding 2 weeks
Use of oral steroids within 1 month prior to the study
Use of concurrent medication e.g. medication that may interfere with the study relatedactivities
Factors suggesting low compliance with study procedures
Possible allergy to ingredients in the study medications
Pregnancy or breast feeding
Study Design
Connect with a study center
Nacka hudmottagning
Nacka, 13183
SwedenSite Not Available
Nacka närsjukhus
Nacka, 13183
SwedenSite Not Available
Hudkliniken, Danderyds sjukhus
Stockholm, 18288
SwedenSite Not Available
Sophiahemmet
Stockholm, 11486
SwedenSite Not Available
Läkarhuset Vällingby
Vällingby, 16862
SwedenSite Not Available
Läkarhuset Vällingby
Vällingby, 16862
SwedenSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.